132 related articles for article (PubMed ID: 27197272)
1. Changes in Epidermal Growth Factor Receptor Gene Copy Number during Oral Carcinogenesis.
Bates T; Kennedy M; Diajil A; Goodson M; Thomson P; Doran E; Farrimond H; Thavaraj S; Sloan P; Kist R; Robinson M
Cancer Epidemiol Biomarkers Prev; 2016 Jun; 25(6):927-35. PubMed ID: 27197272
[TBL] [Abstract][Full Text] [Related]
2. Epidermal growth factor receptor expression and gene copy number in the risk of oral cancer.
Taoudi Benchekroun M; Saintigny P; Thomas SM; El-Naggar AK; Papadimitrakopoulou V; Ren H; Lang W; Fan YH; Huang J; Feng L; Lee JJ; Kim ES; Hong WK; Johnson FM; Grandis JR; Mao L
Cancer Prev Res (Phila); 2010 Jul; 3(7):800-9. PubMed ID: 20570883
[TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical Expression of Epidermal Growth Factor Receptor (EGFR) in Oral Squamous Cell Carcinoma and Oral Potentially Malignant Disorders.
Aamir R; Rauf F; Iqbal F; Yousuf S; Rehman A; Sheikh AK; Muhammad S
Appl Immunohistochem Mol Morphol; 2024 Mar; 32(3):157-162. PubMed ID: 38268382
[TBL] [Abstract][Full Text] [Related]
4. EGFR expression and copy number changes in low T-stage oral squamous cell carcinomas.
Rössle M; Weber CS; Züllig L; Graf N; Jochum W; Stöckli SJ; Moch H; Huber GF
Histopathology; 2013 Aug; 63(2):271-8. PubMed ID: 23763474
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of Diagnostic Significance of Salivary miRNA-184 and miRNA-21 in Oral Squamous Cell Carcinoma and Oral Potentially Malignant Disorders.
Garg A; Urs AB; Koner BC; Augustine J; Guru SA
Head Neck Pathol; 2023 Dec; 17(4):961-968. PubMed ID: 38015343
[TBL] [Abstract][Full Text] [Related]
6. Expression of a truncated epidermal growth factor receptor in oral squamous cell carcinomas.
Kiyota A; Shintani S; Mihara M; Nakahara Y; Ueyama Y; Matsumura T; Todd R; Wong DT
Cancer Lett; 2000 Dec; 161(1):9-15. PubMed ID: 11078908
[TBL] [Abstract][Full Text] [Related]
7. Relationship between epidermal growth factor receptor gene copy number and protein expression in oral cavity squamous cell carcinoma.
Huang SF; Cheng SD; Chien HT; Liao CT; Chen IH; Wang HM; Chuang WY; Wang CY; Hsieh LL
Oral Oncol; 2012 Jan; 48(1):67-72. PubMed ID: 21831696
[TBL] [Abstract][Full Text] [Related]
8. Salivary KLK5 and uPA are potential biomarkers for malignant transformation of OLK and OLP.
Kang Y; Chen J; Li X; Luo M; Chen H; Cui B; Wang L; Lv D; Feng Y; Zhang P
Cancer Biomark; 2021; 31(4):317-328. PubMed ID: 33896830
[TBL] [Abstract][Full Text] [Related]
9. Clinical relevance of serum lipids in the carcinogenesis of oral squamous cell carcinoma.
Qian L; Qian B; Xu J; Yang J; Wu G; Zhao Y; Liu Q; Yuan Z; Fan Y; Li H
BMC Oral Health; 2023 Apr; 23(1):200. PubMed ID: 37013557
[TBL] [Abstract][Full Text] [Related]
10. Urokinase-type plasminogen activator receptor (uPAR), tissue factor (TF) and epidermal growth factor receptor (EGFR): tumor expression patterns and prognostic value in oral cancer.
Christensen A; Kiss K; Lelkaitis G; Juhl K; Persson M; Charabi BW; Mortensen J; Forman JL; Sørensen AL; Jensen DH; Kjaer A; von Buchwald C
BMC Cancer; 2017 Aug; 17(1):572. PubMed ID: 28841839
[TBL] [Abstract][Full Text] [Related]
11. Single-Cell RNA Sequencing Analysis for Oncogenic Mechanisms Underlying Oral Squamous Cell Carcinoma Carcinogenesis with
Hsieh YP; Wu YH; Cheng SM; Lin FK; Hwang DY; Jiang SS; Chen KC; Chen MY; Chiang WF; Liu KJ; Huynh NC; Huang WT; Huang TT
Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35563222
[TBL] [Abstract][Full Text] [Related]
12. Epidermal growth factor receptor intron-1 CA repeat polymorphism on protein expression and clinical outcome in Taiwanese oral squamous cell carcinoma.
Huang SF; Chien HT; Chuang WY; Lai CH; Cheng SD; Liao CT; Wang HM
Sci Rep; 2017 Jul; 7(1):4963. PubMed ID: 28694429
[TBL] [Abstract][Full Text] [Related]
13. Epidermal growth factor receptor copy number in potentially malignant oral disorders and oral squamous cell carcinoma: a short communication and preliminary study.
Bagan JV; Mata-Roig M; Cortio-Gimeno J; Murillo-Cortes J; Hens-Aumente E; Poveda-Roda R; Bagan L
J Oral Pathol Med; 2012 Oct; 41(9):662-6. PubMed ID: 22417006
[TBL] [Abstract][Full Text] [Related]
14. Immunoexpression profile of hypoxia-inducible factor (HIF) targets in potentially malignant and malignant oral lesions: a pilot study.
Gholami S; Chamorro-Petronacci C; Pérez-Sayáns M; Suárez Peñaranda J; Longatto-Filho A; Baltazar F; Afonso J
J Appl Oral Sci; 2023; 31():e20220461. PubMed ID: 37194791
[TBL] [Abstract][Full Text] [Related]
15. Hsa_circ_0005379 regulates malignant behavior of oral squamous cell carcinoma through the EGFR pathway.
Su W; Wang Y; Wang F; Sun S; Li M; Shen Y; Yang H
BMC Cancer; 2019 Apr; 19(1):400. PubMed ID: 31035951
[TBL] [Abstract][Full Text] [Related]
16. Association of epidermal growth factor receptor (EGFR) gene copy number amplification with neck lymph node metastasis in areca-associated oral carcinomas.
Chiang WF; Liu SY; Yen CY; Lin CN; Chen YC; Lin SC; Chang KW
Oral Oncol; 2008 Mar; 44(3):270-6. PubMed ID: 17468034
[TBL] [Abstract][Full Text] [Related]
17. Epidermal Growth Factor Receptor (EGFR) gene copy number (GCN) correlates with clinical activity of irinotecan-cetuximab in K-RAS wild-type colorectal cancer: a fluorescence in situ (FISH) and chromogenic in situ hybridization (CISH) analysis.
Scartozzi M; Bearzi I; Mandolesi A; Pierantoni C; Loupakis F; Zaniboni A; Negri F; Quadri A; Zorzi F; Galizia E; Berardi R; Biscotti T; Labianca R; Masi G; Falcone A; Cascinu S
BMC Cancer; 2009 Aug; 9():303. PubMed ID: 19712476
[TBL] [Abstract][Full Text] [Related]
18. Saliva proteome profiling reveals potential salivary biomarkers for detection of oral cavity squamous cell carcinoma.
Wu CC; Chu HW; Hsu CW; Chang KP; Liu HP
Proteomics; 2015 Oct; 15(19):3394-404. PubMed ID: 26205615
[TBL] [Abstract][Full Text] [Related]
19. Oral Squamous Cell Carcinoma Associated with Precursor Lesions.
McCord C; Kiss A; Magalhaes MA; Leong IT; Jorden T; Bradley G
Cancer Prev Res (Phila); 2021 Sep; 14(9):873-884. PubMed ID: 34193432
[TBL] [Abstract][Full Text] [Related]
20. Gene copy number gain of EGFR is a poor prognostic biomarker in gastric cancer: evaluation of 855 patients with bright-field dual in situ hybridization (DISH) method.
Higaki E; Kuwata T; Nagatsuma AK; Nishida Y; Kinoshita T; Aizawa M; Nitta H; Nagino M; Ochiai A
Gastric Cancer; 2016 Jan; 19(1):63-73. PubMed ID: 25487305
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]